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Research into CAM use by people with diabetes is limited. This study explored CAM use among patients who attend diabetic
clinicsforfollowuptreatment.Specialattentionwaspaidtopatients’changingpatternsofCAMusebeforeandafterdiagnosiswith
Type 2 diabetes, their experience of CAM use, and their management of CAM use with conventional medicines. A retrospective
cross-sectional survey (n = 326) was undertaken in three census regions in Taiwan, including metropolitan, urban, and rural
areas in 2006-7 (87.4% response rate). Participants reported extensive use of CAM with conventional medicines. The prevalence
of CAM use was 22.7% before and 61.0% after diagnosis with Type 2 diabetes with nutritional supplements being the most
commonly used CAM before and after diagnosis. However, the disclosure rate of CAM use to healthcare professionals remained
low (24.6%), and lack of knowledge about CAM ingredients was common (63.4%). Awareness of the widespread use of CAM by
people with Type 2 diabetes is crucial for healthcare professionals. The self-administration of both conventional medicines and
CAMwithoutdisclosureofCAMusetohealthcareprofessionalsmayresultinineﬀectivediabetesmanagementandadverseeﬀects.
CAM information needs to be incorporated into clinical practice and patient and professional education.
1.Introduction
Global estimates of the prevalence of diabetes for 2010 is
around 6.4%, aﬀecting 285 million adults, and will increase
to 7.7%, and 439 million adults by 2030 [1]. Much of this
increase in diabetes will occur in Asia, such as India and
China. With Taiwan being part of the Asia Paciﬁc region,
the prevalence of diabetes is high at around 4.5% [2]; this
disease is, in fact, emerging as a major health issue in
Taiwan. The presence of such a chronic, debilitating, and
possibly painful illness has been identiﬁed as a reason why
patients seek out CAM [3]. In addition, Chang et al. [4]
highlighted that the prevalence of CAM use among diabetic
populations worldwide varies widely, depending on the
deﬁnitionofCAMandthesurveydesignusedbyresearchers.
T h ep r e v a l e n c er a n g e df r o m1 7 %i naU Ks t u d y[ 5] to 72.8%
intheUSA[6]withanaverageof45.5%ofparticipantsinthe
studies reporting the use of some form of CAM. Although
evidence is mounting in support of the use of various CAM
to treat a wide variety of complications of diabetes mellitus
[7],whetherpatientswithType2diabetesactuallyuseCAMs
with known beneﬁts in the management of diabetes is largely
unknown. Especially, the patterns of CAM use among the
Type 2 diabetes population are largely unknown, and no
relevant study has been conducted among patients with Type
2 diabetes in Taiwan.
Research into the reasons for CAM use by people with
diabetes is also limited. Some researchers have identiﬁed
the growth of CAM use in other patient populations as
beingassociatedwiththeperceivedlimitationsofthemedical
paradigm and the apparent failure of conventional medicine
to treat and/or cure chronic illness and catastrophic diseases2 Evidence-Based Complementary and Alternative Medicine
[8]. However, Coulter and Willis [9] suggest that the growth
in CAM use may be related to general societal changes. As
social change and globalization accelerate, faith in the ability
of medical science to solve the problems of human diseases
hasdeclined.Thischangewithinsocietymightbeinterpreted
as part of the ascendancy of patient self-empowerment [10].
This view suggests that patients seek out CAM because they
believe it oﬀers them more personal autonomy and control
over their healthcare decisions [11, 12]. However, several
researchers have found there are more complex reasons
associated with philosophical congruence related to CAM
use such as patients’ values, worldviews, spiritual/religious
philosophies, beliefs, or culture in relation to the nature
and meaning of health and illness [13]. Thus, understanding
the reasons for patients’ CAM use is important as it will
help healthcare professionals to understand the factors that
underpin patients’ beliefs and attitudes towards their health
care. This is the case for any patient population including
people with Type 2 diabetes.
The majority of patients use CAM in conjunction with
conventional medicine, not as an alternative. Some studies
investigated the issue of communication of CAM use with
conventional healthcare professionals, only some referred
to diabetic patients. Egede and his colleagues [14]f o u n d
fewer than 40% of Americans with diabetes who used CAM
disclosedthisinformationtotheirphysicians.Littleisknown
about the disclosure ratesamong Taiwanesediabetes patients
and a recent study showed that 35.4% had discussed CAM
use with their psychiatrists [15]. However, the literature
oﬀers little discussion of the reasons for this limited dis-
closure of CAM use and the apparent communication gap
between patients and healthcare professionals. This lack
of discussion may indicate a deﬁciency in the relationship
between patient and healthcare professional which could
have negatively impact on patient care and health outcomes.
Inaddition,mostpreviousstudiesofCAMuseamongpeople
with diabetes have used data derived from either a medical
expenditure survey or from health insurance claims in the
USA. Thus, these studies mainly focused on CAM users’
characteristics, but have not explained patients’ attitudes,
motivations, and knowledge about CAM use.
Research into the extent of CAM use, why and how it is
used, and disclosure of use to healthcare professionals is vital
as results could help to improve communication between
healthcare professionals and patients and assist in planning
better self-management strategies for patients. The purpose
of this study was to survey people with Type 2 diabetes at
diabetic clinics in order to identify patterns of CAM use
before and after diagnosis, their experience of CAM use, and
theirconcomitantuseofCAMwithconventionaltreatments.
2. Methods
2.1.StudyDesignandSample. Aretrospectivecross-sectional
survey, conducted as a structured interview, was undertaken
between July 2006 and February 2007, in conventional
(Western) hospitals in three regions in Taiwan: Taipei (major
metropolitan area), Kaohsiung (regional area), and Pin-tong
(rural area). In order to conduct a representative survey,
Moser and Kalton’s formula [16] was used to determine the
sample size and the acceptable amount of sampling error was
set at three percent (0.03) for this study. According to this
formula, given that the sampling population (people with
Type 2 diabetes) from these three regions was around 4000,
a sample size of at least 271 participants were necessary to
give signiﬁcant results. Three clinics recruited respondents
at the same time and it was diﬃcult to control the exact
sample size during parallel recruiting. Finally, a total of 373
respondents who were 18 years or older and spoke one of
the following languages: Mandarin, Fujian, or Hakka were
invited to participate in this study, with 47 patients declining
consent. A total of 326 participants completed face-to-face
structured interviews (87.4% response rate).
A two-stage sampling design involving clustering and
simple sampling was used in the selection process. Three
hospitals were selected as a cluster. All respondents within
each cluster were grouped as they entered clinics at the same
time (morning, afternoon, and evening). The appointment
number was the sampling frame and then a simple random
sampling technique was used to draw a sample of the desired
size.
The characteristics of the sample were similar to the
diabetes population distribution published by the Taiwanese
Bureau of Health Census in 2005 indicating that the
sample population in this study reasonably represented the
Taiwanese diabetes population. The human research ethics
committeesofoneofthehospitalsinTaiwanandanAustralia
university approved the study. The other hospitals gave
permission based on these ethics reviews. Written informed
consent to participate in the study was obtained before
proceeding with the interview.
2.2. Survey Instrument. The survey instrument was divided
into three sections: demographic characteristics, pattern of
CAM use, and experience of CAM use. Demographic data
were collected in relation to age, gender, education, income,
duration of disease, and frequency of clinic visits. In the
second section, data were collected about the use of 14
speciﬁc CAM modalities. These modalities were chosen fol-
lowing a literature review, and they represent the modalities
most frequently reported in previous studies undertaken in
Taiwan and internationally. The deﬁnition of the term CAM
used in this study encompasses all the domains proposed
by the National Centre for Complementary and Alternative
Medicine [2],including wholemedicine systems,mind-body
medicine, biologically based practices, manipulative and
body-based practices, and energy medicine. For example,
forbiologicallybasedpractices,nutritionalsupplements,diet
modiﬁcations, Chinese herbal medicines, and non-Chinese
herbal medicines were chosen. A cardboard prompt list with
the names and descriptions of the various CAM modalities
was used to stimulate participants’ memory during the
interviews (see Table 1). Then, the interviewer read the
following statement verbatim to each participant: “Did you
everusethefollowingtherapiessuchasthetreatmentsshown
on this card before diagnosis with diabetes? Have you used
any of them since diagnosis?” Participants who responded
aﬃrmatively were asked to indicate the speciﬁc treatment,Evidence-Based Complementary and Alternative Medicine 3
Table 1: Cardboard prompt list for conducting the face-to-face interviews with the participants explaining the content of fourteen CAM
therapies.
ItemsCAM modalities Speciﬁc treatments
1 Acupuncture To insert ﬁne needles into acupoints, moxibustion, and acupressure
2 Homeopathy Animal, plant, mineral, and synthetic substances in its remedies, isopathy, and ﬂower remedies
3 Chinese herbal medicine Ginseng (Panax ginseng), Dong quai (Angelica sinensis), and Licorice (Glycyrrhiza glabra)
4 Nutrients supplements Multiple-vitamins, vitamins, ﬁsh oil, minerals, and glucosamine
5 Non-Chinese herbs Bilberry, opunita, and fenugreek seed
6 Diet modiﬁcation Organic food, puriﬁed diet (not suggested by conventional healthcare professionals)
7 Cupping, Scraping Cupping: the cup to stick to the skin via suction, Gua-sha, and Tui-na
8 Manipulative-based therapies Chiropractic, osteopathic, and kneading
9 Folk therapies Knife therapy, water therapy, and ﬁre therapy
10 Bioﬁeld therapy The human body kinematics, Gi-gone, Tai-chi, and Reiki,
11 Bioelectromagnetic-based therapies Magnetic ﬁelds, pulsed ﬁelds, and two polar faradisms
12 Supernatural healings Shou-jing, ji-tong, fengshui, bai-bai, divination, and changing individual’s name
13 Aromatherapy Aroma oil, balsam, lavender, and peppermint oil
14 Mind-body therapy Meditation, yoga, and hypnotization
and the reasons for its use. The third section of the survey,
based on a review of Taiwanese and English language litera-
ture, focused on patterns of CAM use including: the reasons
for CAM use, factors inﬂuencing the decision to use CAM,
the administration of CAM with conventional treatments,
the disclosure of CAM use to healthcare professionals, and
the reasons for not using CAM or ceasing CAM.
The content validity of the survey instrument was estab-
lished by a panel of experts. Three academic professionals
and two nurse educators who were expert in CAM, nursing,
researchmethods,ordiabetesevaluatedeachsurveyitemand
also considered whether all the items adequately measured
the dimensions of the content domain. Only a few items,
which were identiﬁed as not adequately presented, were
retained, revised, or replaced following discussion. However,
most of items were determined to be appropriate for assess-
ing each content domain. Because the survey instrument
was originally written in English and was then translated
into Chinese, the reliability of the translation of the survey
instrument content was ensured by using back-translation.
The original and back-translated versions were compared for
equivalence in meaning by a group of bilingual experts. A
pilotstudywasconductedbeforetheonsetofthemainstudy.
The survey conditions of this pilot study were similar to the
actual survey and people who participated in the pilot study
were excluded from the main study.
2.3. Data Collection Procedures. Research assistants (RAs)
randomly selected potential participants from the list of
appointments. Clinic staﬀ assisted with recruitment of
potential participants. After determining that potential par-
ticipants met the inclusion criteria, the information sheet
and the consent form were discussed and signed. The
RA performed the structured interviews and recorded all
answers on the survey instrument.
2.4. Statistical Analyses. The data were scanned for com-
pleteness, and responses were coded and entered into the
computerprogramSPSSforWindowsVersion14.0.Thedata
were examined for outliers, and errors in coding and data
entry were corrected. Demographic and clinical data char-
acterizing the sample were summarized through descriptive
statistical procedures. In order to identify whether people
were more likely to use CAM, and/or use it more fre-
quently/use more modalities, after diagnosis with Type 2
diabetes, two ways of analyzing before and after diagnosis
usage were employed. First, the proportions using each
CAM modality were compared using the McNemar test and
second, the mean numbers of CAM modalities used in each
group were compared using the Wilcoxon Signed Ranks Test.
The level for statistical signiﬁcance for all analyses was set at
a minimum of P<. 05.
3. Results
3.1. Characteristics of Sample. Characteristics of the sample
including demographic and clinical information are pre-
sented in Table 2. The majority of participants were female,
middle-aged, with at least a high school education, had
a household annual income range of US$10,001–30,000
(NT$330,001–990,000) were diagnosed with Type 2 diabetes
less than ten years before the study, and visited the diabetes
clinic monthly. When the key characteristics of gender and
age were compared between the sample and the diabetic
population of Taiwan the results indicated that there were
no statistically signiﬁcant diﬀerences between the sample
and the population (Gender: (χ2(1) = 0.14, P = .84); Age
(χ2(4) = 2.68, P = .61).
3.2. Prevalence and Patterns of Change of CAM Use before and
after Diagnosis of Type 2 Diabetes. Of the 326 participants,
22.7% (n = 74) reported using CAM before diagnosis, with
the number of patients using CAM increasing to 61.0% (n =
199) after diagnosis. The frequency of each CAM modality
used by participants, before and after diagnosis, is presented
in Table 3. Nutritional supplements were most commonly4 Evidence-Based Complementary and Alternative Medicine
Table 2: Demographic characteristics of the overall sample (n =
326).
Sample characteristics Percent
Gender
Male 44.2
Female 55.8
Age (years)
18–44 12.3
45–54 29.1
55–64 31.6
≥65 27.0
Race
Fujan 63.8
China 22.7
Haka 11.0
Aboriginal 7.5
Highest education
< High school graduate 46.9
≥ High school graduate 53.1
House income
≤ US$ 10,000 (NT$330,000) 19.0
US$ 10,001–30,000 (NT$330,001–990,000) 51.5
≥ US$ 30,001 (NT$990,001) 24.0
Unknown 5.5
Duration of diagnosis (years)
1–5 48.5
6–10 30.4
≥10 21.1
Diabetes treatment
Oral agent 85.6
Insulin 9.8
Both 4.6
Clinic visit frequency
≤ Monthly 81.3
> Monthly 18.7
used both, before and after diagnosis. The CAM modalities
thatshowedasigniﬁcantincreaseintheproportionofpeople
using them after diagnosis were nutritional supplements,
Chinese herbal medicines, diet modiﬁcations, manipulative-
based therapies, bioﬁeld therapy, bioelectromagnetic-based
therapies, supernatural healing therapies, and mind-body
therapies. By contrast, the proportions of people using
acupuncture, cupping and scraping, and aromatherapy were
not found to be diﬀerent in the groups before and after
diagnosis.
Use of multiple combinations of CAM (between two and
twelve modalities) was reported by 11.0% of participants
before diagnosis with Type 2 diabetes and 55.2% after
diagnosis. A highly signiﬁcant diﬀerence was found in the
mean numbers of modalities used before (mean = 0.48) and
after (mean = 2.20) diagnosis (T(324) =− 11.73, P<. 001).
TheresultindicatesthatpeoplewithType2diabetesreported
more use of CAM after being diagnosed with diabetes.
Physicians 6%
Phamacists 6%
CAM
practitioners 6%
Others 2%
Nurses 1%
Media 10%
Medical journal
3%
Families
39%
Friends
27%
Figure 1: Information sources of CAM used by participants.
3.3. The Reasons for CAM Use. For each CAM, users were
asked to diﬀerentiate between their use of CAM to manage
their diabetes, to manage diabetic complications, or for
others reasons. Of the participants who used CAM, only
24.9% used CAM to control diabetes directly and only 3.2%
used CAM to treat diabetic complications; the majority
(71.9%) used CAM for other health-related conditions.
Although the majority used CAM for reasons other than
to treat diabetes and its complications, they did expect
some beneﬁts in relation to diabetes from the usage. The
most common expectation of the beneﬁts, ranked highest
to lowest, were as follows: to reduce symptoms (51.3%), to
maintain body health (47.2%), to improve energy (25.4%),
to increase metabolism (17.3%), and others, such as to help
body self-healing, to improve emotional well-being, to take
fewer conventional medicines, and to cure other diseases.
3.4. Patients’ Experience of Decision-Making about CAM Use.
Of the after-diagnosis users (n = 199) identiﬁed from
the survey respondents, 197 users completed this section.
The majority initially chose CAM because people around
them believed in CAM (49.2%) (see Table 4). The primary
sourceofCAMinformationwasfamilies(49.2%)andfriends
(33.5%), with only 3% identifying CAM practitioners as
the primary information source (see Figure 1). However, the
main decision on CAM use was still taken by the participants
themselves (75.6%), while only 18.3% reported that the
decision to use CAM was made by family members and 2%
reported that the decision was made by friends.
3.5. CAM Knowledge among Users. A surprising 63.4% of
after-diagnosis users of biologically based therapies (n =
172) reported that they did not know which complementary
medicine they were actually taking. Within this group,
26.6% did not know anything about their CAM products,
30.3% could identify that their CAM products came from
CAM practitioners, and 43.1% knew that the ingredients
were stated on the label. Of 172 participants, only 30.8%
did not change the time at which they administered their
conventional medication. However, 60.4% of participantsEvidence-Based Complementary and Alternative Medicine 5
Table 3: Comparative frequency of use of CAM modalities before- and after-diagnosis with Type 2 diabetes.
CAM modalities
Before
diagnosis
%
After
diagnosis
%
P value
Whole medical systems
Acupuncture 5.5 6.7 .60
Homeopathy 0.0 0.0 NA
Biologically based practices
Chinese herbal medicines 8.0 27.9 <.001
Nutritional supplements 8.6 41.1 <.001
Diet modiﬁcation 1.8
∗ 13.2 .003
Non-Chinese herbs 0.3
∗ 3.4 .006
Manipulative- and body-based practices
Cupping, scraping 5.8 6.4 .84
Manipulative-based therapies 4.6 13.5 <.001
Folk therapies 0.3
∗ 0.6 1.000
Energy medicine
Bioﬁeld therapy 1.8
∗ 9.2 <.001
Bioelectromagnetic-based therapies 3.7 10.1 .001
Mind-body medicine
Supernatural healings 4.9
∗ 11.0 <.001
Mind-body therapies 1.5
∗ 3.7 .04
Aromatherapy 1.2
∗ 0.3
∗ .25
∗Cells have expected count less than 5.
Table 4: The reasons for starting CAM use.
Initial reasons for CAM use n = 197 %1
People around them believed in CAM treatment 97 49.2
They believed in CAM 76 38.6
CAM was consistent with their culture 23 11.7
CAM was perceived to have fewer side eﬀects than conventional medicine 20 10.1
CAM was recommended by healthcare professionals 14 7.1
They were dissatisﬁed with conventional medicine 2 1.0
1The total percentage is greater than 100% because the multiple responses were allowed in the question.
tookconventionalmedicationandCAMproductsatseparate
times to prevent interactions while 5.8% of participants
either reduced the dose of conventional medication without
informing conventional healthcare professionals or even
stopped conventional medication altogether when they took
CAM products.
3.6. Decisions Regarding Disclosure of CAM Use. Among 197
participants who completed this section, two participants
did not visit a healthcare professional during the time they
were using CAM. Of 195 participants who saw a health-
care professional and used CAM along with conventional
medicines, only 24.6% had disclosed their CAM use to
a healthcare professional. This indicated that the majority
reported deciding to take a CAM product concurrently
with conventional medicine but without seeking advice
from a healthcare professional. The reasons people gave for
not informing their doctor about their CAM use, were:
(a) that they never thought of it (55.8%); (b) that they
feel CAM use is safe, thus there is no need to discuss its
use (51.9%); (c) that healthcare professionals do not ask
about their CAM use (22.4%); (d) that they think that
healthcare professionals will discourage CAM use (7.5%);
(e) that they think there is not suﬃcient time to discuss
CAM use (4.1%); and (f) that they think that health-
care professionals do not have an adequate knowledge of
CAM (4.1%).
For the minority (n = 48) who informed the health-
care professionals of their CAM use, the responses from
healthcare professionals were quite negative and passive,
including: (a) stating that it was entirely a matter for the
patient and oﬀering no comment about the patient’s CAM
use (47.9%); (b) warning them of possible side eﬀects of
CAM use (8.3%); and (c) discouraging them from taking
it (6.3%). Only 15 participants (31.3%) reported that their
healthcare professionals encouraged them to use CAM.6 Evidence-Based Complementary and Alternative Medicine
4. Discussion
In this study, more than three in ﬁve people with Type 2
diabetes had used at least one type of CAM after diagnosis,
which is consistent with some previous studies [17, 18];
however, this usage is higher than the studies in Malaysia
(35.5%) [3], Turkish (41.0%) [19], and Germany (18.4%)
[12]. It is important to note that the reported prevalence
of CAM use in general varies widely in the literature [4,
20] because research design, methods of data collection,
time frames, sample population, response rates, and the
operational deﬁnition of what constitutes a CAM greatly
aﬀect the estimation of CAM use. The high level of CAM
useconcomitantlywithconventionalmedicinesfoundinthis
study conﬁrms that patients do not use CAM to replace
conventional medicine but rather to complement it.
The top ﬁve CAM modalities most commonly used
before diagnosis were nutritional supplements, Chinese
herbal medicines, cupping and scraping, acupuncture, and
supernatural healing therapies. This pattern slightly changed
after diagnosis, with use of manipulative- and body-based
therapiesanddietmodiﬁcationssigniﬁcantlyincreasingafter
diagnosis whereas acupuncture and cupping and scraping
usedecreased.ThesechangesmayindicatethatCAMbecame
a self-care strategy for people with Type 2 diabetes not
only to manage their diabetes but also their general health
and well-being. The patterns of CAM use after diagnosis
were similar to some studies in the USA [21] and Thailand
[22] and contrasted with the studies in the UK [5]a n d
India [23] in which naturopathy, ayurveda, homeopathy,
reﬂexology, and aromatherapy were popular with people
living with diabetes. While nutritional supplements and diet
modiﬁcation are cross-cultural phenomena, Chinese herbal
medicine and supernatural healing therapies are Oriental,
and their popularity in Taiwan indicates that traditional
culture and religious beliefs heavily inﬂuence the selection
of CAM therapies.
Indeed, there are nine (9) therapies for which the
usage rate signiﬁcantly increases after diagnosis with dia-
betes. These therapies include Chinese herbal medicine,
manipulative- and body-based therapies, diet modiﬁcations,
bioﬁeld therapy, and supernatural healings, which are all
related to traditional Chinese medicine (TCM). TCM com-
prises of a wide range of techniques, such as acupunc-
ture, electro-acupuncture, moxibustion, auriculotherapy,
cupping, Tui-na (massage), herbal medicine, pharmacology,
dietary therapy, Qigong, Taichi, and Feng-shui. The theory
of TCM is based on a number of philosophical frameworks
including the theory of yin and yang. The treatments listed
above are intended to restore an imbalance of yin and
yang [24], for example, Chinese dietary therapy is the most
basic treatment in TCM which classiﬁes food as either
y i no ry a n go rt o x i cf o o d s[ 25]. Taiwan is an island oﬀ
the eastern coast of Asia with a population of twenty-
three million people. More than 80% of Taiwanese people
are the descendants of immigrants coming from southeast
China since the 16th century (Fujianese and Hakka). These
immigrants brought traditional Chinese medicine (TCM) to
Taiwan; hence, its practitioners have been providing health
care service privately to Taiwanese for several centuries.
People share these beliefs and common experiences that
aﬀect their engagement of behaviours in treating, preventing
or modifying illness.
Since people viewed CAM use as one element in an
individually mediated approach to the self-management
of their health and illness, it is important for healthcare
professionals to be aware of which CAM modalities are
commonly used by people after diagnosis with Type 2
diabetes and why. The majority of participants in this study
primarily used CAM for other health-related conditions; to
relieve symptoms related to conditions other than Type 2
diabetes, to maintain body health, and to improve energy,
thus conﬁrming the ﬁndings of previous studies [26, 27]. It
seems that the majority of those who used CAM considered
wellness and quality of life as more important than directly
treating diabetes. However, the opinion of others heavily
inﬂuenced the decision-making process and the most com-
mon reason for initial CAM use, reported by participants,
was that people close to them believed in the eﬃcacy of
CAM. As the main sources of CAM information identiﬁed
by the participants were informal and unscientiﬁc, there
may be concern about the quality and safety of CAMs used
by people with Type 2 diabetes, especially as they were
frequentlyusingCAMtogetherwithconventionalmedicines.
Inaddition,limiteddisclosureofCAMusetotheirhealthcare
professionals, and a negative or passive reaction from the
healthcare professionals upon disclosure complicates the sit-
uation which may result in inadequate treatment, decreased
health outcomes, and higher costs for the health care
system.
5. Implications
Awareness of widespread use of CAM modalities by people
with Type 2 diabetes is crucial for healthcare professionals.
Our study indicated people with Type 2 diabetes often
use unreliable CAM information sources, have a lack of
knowledge about the CAM products they are taking, and
self-administer both types of medicines concomitantly.
Healthcare professionals need to acknowledge CAM use,
learn to discuss CAM use with their patients, and be able
to do so in an open-minded, respectful manner. Moreover,
healthcare professionals need to be able to provide accurate
evidence-based advice about CAM. This information will be
crucial to health professionals in providing eﬀective care and
needs to be incorporated into professional education and
research, as well as clinical practice. Education about CAM,
however, should not only focus on healthcare professional
education but should also consider patient education. This
study has highlighted concerns about patients’ decision-
making processesrelatedtoCAMuse,including poorquality
information sources and lack of guidance. Therefore, up-to-
date evidence-based CAM information should be provided
to patients as part of diabetes routine management and
counselling. Given that the opinions of others profoundly
inﬂuencedpatients’decisionsaboutCAMuse,patienteduca-
tionaboutCAMshouldalsoinvolvepatients’socialnetworks
such as family. It is therefore important to empower patientsEvidence-Based Complementary and Alternative Medicine 7
withevidence-basedinformationandintegrateCAMmodal-
ities into chronic disease self-management programs. This
shift towards a holistic model of care will provide optimal
patient care in the future.
6. Limitations
The design involved retrospective data collection in which
recall bias can not be excluded, especially regarding CAM
use before and after the diagnosis of diabetes. The use of
cardboard prompt list with the names and descriptions of
the various CAM modalities was used assist with recall.
Additionally, if recall was low, it was probably similarly low
across the sample because there are no obvious reasons to
expect diﬀerential reporting of CAM use compared to other
previous Taiwanese studies. A second limitation is sampling
bias. Cluster sampling tends to be less accurate than other
samplings. Therefore, to avoid sample error, the discrepancy
between sample characteristics and the true population
characteristics were compared and showed homogeneity
between the two groups. The nonresponse rate in this study
also remained low, which minimized the sampling bias.
7. Conclusion
The majority of people with Type 2 diabetes in Taiwan
are likely to use both conventional medicine and CAM in
managing their illness and health without using appropriate
information sources to support their decision or disclosing
their CAM use to their healthcare professional. Although
evidence is mounting in support of the use of various
CAM to treat a wide variety of complications of diabetes,
whether patients with Type 2 diabetes actually use CAM
with known beneﬁts in the management of diabetes is
largely unknown. A signiﬁcant increase in the usage of
Chinese herbal medicines, nutritional supplements and
non-Chinese herbal medicines following diagnosis with
Type 2 diabetes and the unsupervised use of these CAM
modalities with conventional medicines bears the risk of
CAM-drug interactions which may compromise the optimal
management of diabetes. The ﬁndings in this study can be
used to improve healthcare professional awareness, patient
assessment, healthcare professional and patient education,
and clinical research. Improving CAM education for patients
and healthcare professionals and developing an open and
honest communication between patients and healthcare
professionals is imperative for eﬀective patient care when
managing a chronic disease.
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